AI assistant
Sending…
MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2021
Aug 5, 2021
30608_dirs_2021-08-04_5de7aad4-1dc6-4c65-8b39-3c7ad4afba7c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK: 0001157601
Period of Report: 2021-08-02
Reporting Person: Waltermire Robert E. (Senior VP, Chief Pharma Dev.)
More from MADRIGAL PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 24
Annual Report
2026
Feb 19
Regulatory Filings
2026
Feb 19
Regulatory Filings
2026
Jan 30
Director's Dealing
2026
Jan 26